nocodazole has been researched along with Progeria in 1 studies
Progeria: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larrieu, D | 1 |
| Britton, S | 1 |
| Demir, M | 1 |
| Rodriguez, R | 1 |
| Jackson, SP | 1 |
1 other study available for nocodazole and Progeria
| Article | Year |
|---|---|
Chemical inhibition of NAT10 corrects defects of laminopathic cells.
Topics: Cell Line, Tumor; Cell Nucleus; Chromatin; Enzyme Inhibitors; Humans; Hydrazones; Lamin Type A; Micr | 2014 |